Replication-competent retrovirus vectors for cancer gene therapy

Related Experiment Videos

Chien-Kuo Tai1, Noriyuki Kasahara

  • 1Department of Life Science and Institute of Molecular Biology, National Chung Cheng University, Min-Hsiung, Chia-Yi, Taiwan.

Frontiers in Bioscience : a Journal and Virtual Library
|November 6, 2007
PubMed

Insights

Replication-competent retrovirus (RCR) vectors show promise for cancer treatment by selectively targeting tumors. These engineered viruses can deliver therapeutic genes and persist long-term, offering potential for improved patient survival.

Area of Science:

  • Oncolytic virotherapy
  • Retroviral vector technology
  • Cancer therapeutics

Background:

  • Oncolytic virotherapy utilizes viruses to combat cancer.
  • Replication-competent retrovirus (RCR) vectors, based on murine leukemia virus (MLV), offer unique therapeutic potential.
  • MLV's intrinsic tumor selectivity and efficient in vivo gene transfer are key advantages.

Purpose of the Study:

  • To evaluate the potential of RCR vectors for cancer treatment.
  • To explore the mechanisms of RCR vector-mediated tumor targeting and gene delivery.
  • To assess the efficacy of RCR vectors combined with suicide gene therapy.

Main Methods:

  • Development and characterization of RCR vectors based on MLV.
  • In vivo studies in various tumor models to assess tumor selectivity and gene transfer efficiency.
  • Evaluation of RCR vectors encoding suicide genes for prodrug-mediated cancer cell killing.
  • Assessment of long-term viral persistence and therapeutic benefit through multiple prodrug cycles.

Main Results:

  • MLV-based RCR vectors demonstrate intrinsic tumor selectivity, avoiding quiescent cells.
  • High efficiencies (>99%) of selective and stable gene transfer into solid tumors were achieved in vivo.
  • RCR vectors with suicide genes enabled synchronized cancer cell killing upon prodrug administration.
  • Stable integration of RCR vectors allows for long-term viral persistence and repeated therapeutic cycles.

Conclusions:

  • RCR vectors represent a promising platform for oncolytic virotherapy.
  • Their ability for stable gene transfer, tumor selectivity, and long-term persistence offers significant therapeutic advantages.
  • Ongoing research and GMP manufacturing development are paving the way for clinical trials, particularly in glioblastoma.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.5K